Grade 2 Meningioma — Trials

Grade 2 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03016091	A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma	terminated	Phase 2	18	Rabin Medical CenterOTHER	1	Feb 18, 2025	clinicaltrials
NCT01234805	Yoga Therapy in Treating Patients With Malignant Brain Tumors	terminated	N/A	9	Wake Forest University Health SciencesOTHER	1	Jul 3, 2018	clinicaltrials
NCT02967380	Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	terminated	N/A	14	University of Southern CaliforniaOTHER	1	Mar 27, 2017	clinicaltrials
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Data updated 22 days agoSource updated Feb 18, 2025source: clinicaltrials